Ann F. Hoffman
Papers
2
Total Citations
35
H-Index
2
About
Ann F. Hoffman is a pioneering researcher in the field of high-content screening (HCS) and drug discovery, whose work has helped shape the early development and practical application of automated cellular imaging technologies within the pharmaceutical industry. Writing during a formative period for HCS in the mid-2000s, Hoffman provided some of the first comprehensive industry-facing perspectives on the technology's potential, bridging the gap between academic innovation and real-world pharmaceutical application. Her 2006 paper offering a pharmaceutical company user's perspective on HCS garnered 33 citations, reflecting its value as an early reference point for researchers and industry professionals navigating this emerging landscape. Alongside this, her work on the preparation of cells for high-content screening addressed a critical and often overlooked practical challenge — ensuring that cell biologists could accurately select appropriate cells and cellular markers at scale. Collectively, Hoffman's contributions helped lay the groundwork for standardizing HCS workflows, empowering a generation of drug discovery scientists to harness automated imaging more effectively and rigorously in their search for new therapeutics.
Research Focus
Key Achievements
Top Papers
- 1
- 2The Preparation of Cells for High-Content Screening2 citations · 2006
Key Collaborators
Related papers
- A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery
- The Preparation of Cells for High-Content Screening
- Can flow cytometry play a part in cell based high‐content screening?
- Human Pluripotent Stem Cells: The Development of High-Content Screening Strategies
- Introduction
Researchers in this area
Labs working in this area
Suggested by topic similarity — not advertising or endorsement.